150 related articles for article (PubMed ID: 25147374)
1. Asparaginase allergies: it's all in the genes.
Wetzler M
Blood; 2014 Aug; 124(8):1206-7. PubMed ID: 25147374
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
Fernandez CA; Smith C; Yang W; Daté M; Bashford D; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Turner V; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
Blood; 2014 Aug; 124(8):1266-76. PubMed ID: 24970932
[TBL] [Abstract][Full Text] [Related]
3. HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.
Kutszegi N; Yang X; Gézsi A; Schermann G; Erdélyi DJ; Semsei ÁF; Gábor KM; Sági JC; Kovács GT; Falus A; Zhang H; Szalai C
Haematologica; 2017 Sep; 102(9):1578-1586. PubMed ID: 28596278
[TBL] [Abstract][Full Text] [Related]
4. HLA alleles associated with asparaginase hypersensitivity in Chinese children.
Chua GT; Rosa Duque JS; Cheuk DKL; Leung AWK; Wong WHS; Liu APY; Lee PPW; Ha SY; Chiang AKS; Ho MHK; Chu WK; Chan YS; Luk CW; Ling ASC; Kwan MYW; Yiu OKF; Wong ICK; Lau YL; Li CK; Leung WH; Chan GCF; Ip P; Kwok J
J Hematol Oncol; 2021 Oct; 14(1):182. PubMed ID: 34717720
[TBL] [Abstract][Full Text] [Related]
5.
Liu S; Gao C; Wu Y; Lin W; Li J; Xue T; Wang L; Zheng H; Zhang R
Pharmacogenomics; 2021 Nov; 22(17):1135-1142. PubMed ID: 34747637
[No Abstract] [Full Text] [Related]
6. Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation.
Kloos RQ; Pieters R; Escherich G; van der Sluis IM
Pediatr Blood Cancer; 2016 Nov; 63(11):1928-34. PubMed ID: 27376478
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia.
Rajić V; Debeljak M; Goričar K; Jazbec J
Leuk Lymphoma; 2015; 56(11):3103-8. PubMed ID: 25697915
[TBL] [Abstract][Full Text] [Related]
8. Rapid desensitization for L-asparaginase hypersensitivity.
Bonno M; Kawasaki H; Hori H; Umemoto M; Komada Y; Sakurai M
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):571-2. PubMed ID: 9564820
[No Abstract] [Full Text] [Related]
9. HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium.
Gagné V; St-Onge P; Beaulieu P; Laverdière C; Leclerc JM; Tran TH; Sallan SE; Neuberg D; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics; 2020 Jun; 21(8):541-547. PubMed ID: 32372697
[No Abstract] [Full Text] [Related]
10. Managing hypersensitivity to asparaginase in pediatrics, adolescents, and young adults.
Shinnick SE; Browning ML; Koontz SE
J Pediatr Oncol Nurs; 2013; 30(2):63-77. PubMed ID: 23380527
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of L-asparginase in children with advanced leukemia.
Land VJ; Sutow WW; Fernbach DJ; Lane DM; Williams TE
Cancer; 1972 Aug; 30(2):339-47. PubMed ID: 4626307
[No Abstract] [Full Text] [Related]
12. Is Erwinase Necessary for all Children With ALL and Allergic Reactions to E. coli Asparaginase?
Pui CH
Pediatr Blood Cancer; 2016 Apr; 63(4):587-8. PubMed ID: 26739648
[No Abstract] [Full Text] [Related]
13. Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia.
Burke MJ; Rheingold SR
Leuk Lymphoma; 2017 Mar; 58(3):540-551. PubMed ID: 27546298
[TBL] [Abstract][Full Text] [Related]
14. Asparaginase treatment in infants with acute lymphoblastic leukemia; pharmacokinetics and asparaginase hypersensitivity in Interfant-06.
Albertsen BK; Harila-Saari A; Jahnukainen K; Lähteenmäki P; Riikonen P; Möttönen M; Lausen B
Leuk Lymphoma; 2019 Jun; 60(6):1469-1475. PubMed ID: 30632847
[TBL] [Abstract][Full Text] [Related]
15. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
16. Erwinia asparaginase: coming closer to an understanding of its use in pediatric acute lymphoblastic leukemia?
Maloney KW
Pediatr Blood Cancer; 2010 Feb; 54(2):189-90. PubMed ID: 19967774
[No Abstract] [Full Text] [Related]
17. L-asparaginase: clinical, biochemical, pharmacological, and immunological studies.
Capizzi RL; Bertino JR; Skeel RT; Creasey WA; Zanes R; Olayon C; Peterson RG; Handschumacher RE
Ann Intern Med; 1971 Jun; 74(6):893-901. PubMed ID: 5281051
[No Abstract] [Full Text] [Related]
18. [The adverse reaction of L-asparaginase and its prevention].
Lai YH; Wu ZL; Chen FX
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):533-4. PubMed ID: 16083559
[No Abstract] [Full Text] [Related]
19. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
Larson RA; Fretzin MH; Dodge RK; Schiffer CA
Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients.
Wang B; Relling MV; Storm MC; Woo MH; Ribeiro R; Pui CH; Hak LJ
Leukemia; 2003 Aug; 17(8):1583-8. PubMed ID: 12886246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
